• PDF: Delivered by email usually within 48 UK business hours.

Biomerieux Sa Market Share Analysis

  • Publication Date:December 2011
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:181

Biomerieux Sa Market Share Analysis

Summary

GlobalData's new report, 'Biomerieux Sa Market Share Analysis' provides in-depth information on BioMerieux S.A.'s market position in the different medical equipment markets it operates in. The report provides BioMerieux S.A. market share information in four key market categories - Microbiology Culture, Infectious Immunology, Immuno Chemistry and Haematology. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Global company shares (in Revenues) information for the key markets BioMerieux S.A. operates in - In Vitro Diagnostics.
  • BioMerieux S.A.'s company shares (in Revenues) information for all the key countries the company has presence in - Australia, China, India, Japan, France, Spain, United Kingdom, Italy, Germany, United States, Canada and Brazil.
  • BioMerieux S.A.'s company shares (in Revenues) information for all the key market categories the company has presence in - Microbiology Culture, Infectious Immunology, Immuno Chemistry and Haematology.
  • All the key data-points are for 2010 and cover all the key regions - South and Central America, Europe, Middle East and Africa, North America and Asia-Pacific.
  • Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries.
  • The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in..
  • Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

  • Develop sales and marketing strategies by identifying who-stands-where in the markets, BioMerieux S.A. operates in.
  • Plan your competition strategies by identifying the company's shares in the markets and geographic regions it operates in.
  • Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
  • Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
  • Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to BioMerieux S.A.'s market positions.

This report covers the following industry codes:
SIC Code: 8071
NAICS Code: 621512

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets/Categories Covered
    • 3.1 In Vitro Diagnostics
      • 3.1.1 Haematology
      • 3.1.2 Immuno Chemistry
      • 3.1.3 Infectious Immunology
      • 3.1.4 Microbiology Culture
  • 4 Company Snapshot
    • 4.1 Key Information
    • 4.2 Company Overview
    • 4.3 Financial Performance
    • 4.4 SWOT Snapshot
  • 5 Business Description
    • 5.1 Business Overview
    • 5.2 Clinical Applications
      • 5.2.1 Overview
      • 5.2.2 Financials
      • 5.2.3 Market View
    • 5.3 Industrial Applications
      • 5.3.1 Overview
      • 5.3.2 Financials
    • 5.4 Major Products and Services
      • 5.4.1 Overview
  • 6 History
  • 7 Business Strategy
    • 7.1 Mission Statement
  • 8 SWOT Analysis
    • 8.1 Overview
    • 8.2 bioMerieux S.A. Strengths
      • 8.2.1 Strong Growth in Top and Bottom Line
      • 8.2.2 Global Presence
      • 8.2.3 Proprietary Technologies
      • 8.2.4 Strong Research and Development Activities
    • 8.3 bioMerieux S.A. Weaknesses
      • 8.3.1 Product Recalls
      • 8.3.2 Legal Disputes
    • 8.4 bioMerieux S.A. Opportunities
      • 8.4.1 Market Growth in Emerging Economies
      • 8.4.2 Growing In Vitro Diagnostics Market
      • 8.4.3 Market Opportunity - Infectious Disease
      • 8.4.4 Strategic Acquisitions
      • 8.4.5 Business Development Agreements
    • 8.5 bioMerieux S.A. Threats
      • 8.5.1 Introduction of Innovative Technologies
      • 8.5.2 Stringent Governmental Regulations
      • 8.5.3 Industry Consolidation Challenges
  • 9 Competitors
  • 10 Competitive Landscape
    • 10.1 In Vitro Diagnostics, Global, Market Share (%), 2010
  • 11 bioMerieux S.A. Medical Equipment Market Share Analysis
    • 11.1 bioMerieux S.A., In Vitro Diagnostics, Global, Market Share (2010)
    • 11.2 bioMerieux S.A., Asia-Pacific, Market Share (2010)
    • 11.3 bioMerieux S.A., Europe, Market Share (2010)
    • 11.4 bioMerieux S.A., Middle East and Africa, Market Share (2010)
    • 11.5 bioMerieux S.A., North America, Market Share (2010)
    • 11.6 bioMerieux S.A., South and Central America, Market Share (2010)
  • 12 bioMerieux S.A. Medical Equipment Market Share Analysis by Category
    • 12.1 bioMerieux S.A., In Vitro Diagnostics, Global, Category Revenue Share (2010)
    • 12.2 bioMerieux S.A., Asia-Pacific, Category Revenue Share (2010)
      • 12.2.1 bioMerieux S.A., Australia, Category Revenue Share (2010)
      • 12.2.2 bioMerieux S.A., China, Category Revenue Share (2010)
      • 12.2.3 bioMerieux S.A., India, Category Revenue Share (2010)
      • 12.2.4 bioMerieux S.A., Japan, Category Revenue Share (2010)
      • 12.2.5 bioMerieux S.A., Other Asia-Pacific, Category Revenue Share (2010)
    • 12.3 bioMerieux S.A., Europe, Category Revenue Share (2010)
      • 12.3.1 bioMerieux S.A., France, Category Revenue Share (2010)
      • 12.3.2 bioMerieux S.A., Germany, Category Revenue Share (2010)
      • 12.3.3 bioMerieux S.A., Italy, Category Revenue Share (2010)
      • 12.3.4 bioMerieux S.A., Spain, Category Revenue Share (2010)
      • 12.3.5 bioMerieux S.A., United Kingdom, Category Revenue Share (2010)
      • 12.3.6 bioMerieux S.A., Other Europe, Category Revenue Share (2010)
    • 12.4 bioMerieux S.A., Middle East and Africa, Category Revenue Share (2010)
    • 12.5 bioMerieux S.A., North America, Category Revenue Share (2010)
      • 12.5.1 bioMerieux S.A., Canada, Category Revenue Share (2010)
      • 12.5.2 bioMerieux S.A., United States, Category Revenue Share (2010)
    • 12.6 bioMerieux S.A., South and Central America, Category Revenue Share (2010)
      • 12.6.1 bioMerieux S.A., Brazil, Category Revenue Share (2010)
      • 12.6.2 bioMerieux S.A., Other South and Central America, Category Revenue Share (2010)
  • 13 Key Employees
  • 14 Key Employee Biographies
  • 15 Company Statement
  • 16 Locations and Subsidiaries
    • 16.1 Head Office
    • 16.2 Other Locations & Subsidiaries
  • 17 Financial Deals Landscape
    • 17.1 bioMerieux S.A., Deals Volume Summary, 2006 to YTD 2011
  • 18 bioMerieux S.A. Detailed Deal Summary
    • 18.1 Venture Financing
      • 18.1.1 AviaraDx Raises $8 Million In Series A Financing
      • 18.1.2 AdvanDx Secures $15 Million Series C Financing
      • 18.1.3 Arcturus Bioscience Secures $8 Million In Financing
    • 18.2 Partnerships
      • 18.2.1 bioMerieux Enters Into Licensing Agreement With ProteoSys
      • 18.2.2 ExonHit Therapeutics Amends Its Licensing Agreement With bioMerieux
      • 18.2.3 bioMerieux Enters Into An Agreement With NuGEN Technologies
      • 18.2.4 biomerieux Signs A Licensing Agreement With Labtech Systems
      • 18.2.5 bioMerieux Enters Into Licensing Agreement With NorChip
      • 18.2.6 Bio-Rad Laboratories Enters Into Licensing Agreement With bioMerieux
      • 18.2.7 Lumora Enters Into Licensing Agreement With bioMerieux
      • 18.2.8 bioMerieux Extends Its Licensing Agreement With ExonHit Therapeutics
      • 18.2.9 bioMerieux Enters Into Licensing Agreement With DiagnoSwiss
      • 18.2.10 Roche Diagnostics Signs An Agreement With bioMerieux
      • 18.2.11 Biomerieux Enters Into Co-Development Agreement With Biocartis
      • 18.2.12 bioMerieux Signs Co-Development Agreement With GlaxoSmithKline
      • 18.2.13 Ferrer inCode Enters Into An Agreement With bioTheranostics
      • 18.2.14 Royal Philips Electronics Enters Into An Agreement With bioMerieux
      • 18.2.15 bioMerieux Enters Into Research Agreement With CEA
      • 18.2.16 bioMerieux Enters Into An Agreement With GlaxoSmithKline
      • 18.2.17 bioTheranostics Signs An Agreement With Lab21
      • 18.2.18 bioMerieux Enters Into Research Agreement With Foundation for Innovative New Diagnostics
      • 18.2.19 bioMerieux Enters Into An Agreement With Hitachi High-Technologies
      • 18.2.20 bioMerieux Enters Into An Agreement With Wescor
      • 18.2.21 bioMerieux Forms Joint Venture With Shanghai Kehua Bio-engineering
      • 18.2.22 Sysmex Forms Joint Venture With bioMerieux
      • 18.2.23 Sysmex Corporation Enters Into An Agreement With Biomerieux
      • 18.2.24 AdvanDx Enters Into An Agreement With bioMerieux
      • 18.2.25 Biomerieux Enters Into An Agreement With Cepheid
      • 18.2.26 bioMerieux Forms Joint Venture With Chinese Academy of Medical Sciences
      • 18.2.27 B•R•A•H•M•S Enters Into An Agreement With bioMerieux
      • 18.2.28 Abaxis Enters Into Licensing Agreement With bioMerieux
      • 18.2.29 Gen-Probe Enters Into Licensing Agreement With bioMerieux
      • 18.2.30 LabCorp Enters Into An Agreement With Arcturus Bioscience
      • 18.2.31 Affymetrix Extends Its Agreement With bioMerieux
      • 18.2.32 Gen-Probe Enters Into An Agreement With bioMerieux
    • 18.3 Equity Offering
      • 18.3.1 Labtech Systems Completes Private Placement Of $1.79 Million With Biomerieux
    • 18.4 Asset Transactions
      • 18.4.1 bioMerieux Sells Hemostasis Business To Trinity Biotech
    • 18.5 Acquisition
      • 18.5.1 bioMerieux Completes Acquisition Of AES Laboratoire
      • 18.5.2 bioMerieux Acquires Argene
      • 18.5.3 bioMerieux Completes Acquisition Of Meikang Biotech (Shanghai)
      • 18.5.4 bioMerieux Sells Minority Stake In ExonHit Therapeutics
      • 18.5.5 bioMerieux Acquires PML Microbiologicals From Pelican Life Sciences
      • 18.5.6 bioMerieux Acquires AviaraDx
      • 18.5.7 bioMerieux Acquires AB BIODISK
      • 18.5.8 bioMerieux Acquires BTF From Kestrel Capital
      • 18.5.9 Biomerieux Acquires Biomedics
  • 19 Recent Developments
    • 19.1 Strategy and Business Planning
      • 19.1.1 Nov 18, 2011: bioMérieux Initiative To Support European Antibiotic Awareness Day
      • 19.1.2 May 05, 2011: bioMérieux and Labor Berlin To Establish Center Of Excellence In Laboratory Diagnostics
      • 19.1.3 Mar 17, 2008: BioMerieux Enters Into Strategic Partnership With Hitachi
      • 19.1.4 Dec 13, 2007: BioMerieux Opens South African Subsidiary
    • 19.2 Financial Announcements
      • 19.2.1 Oct 20, 2011: bioMerieux Reports Revenues Of €347.3m In Q3 2011
      • 19.2.2 Sep 06, 2011: bioMerieux Reports Net Sales Of €673.4m In H1 2011
      • 19.2.3 Apr 21, 2011: bioMerieux Reports Revenues Of €327.6m In Q1 2011
      • 19.2.4 Mar 08, 2011: bioMerieux Reports Net Sales Of €1.3 Billion In 2010
      • 19.2.5 Sep 06, 2010: bioMerieux Reports Net Sales Of EUR650.6 Million In H1 2010
      • 19.2.6 Apr 21, 2010: bioMerieux Reports Net Sales Of EUR306.6 Million In Q1 2010
      • 19.2.7 Mar 08, 2010: bioMerieux Reports Net income Of EUR148.2 Million In 2009
      • 19.2.8 Oct 20, 2009: bioMerieux Reports Net Income Of EUR305.9 Million In Q3 2009
      • 19.2.9 Sep 07, 2009: bioMerieux Reports Net Income Of EUR63.4 Million In H1 2009
      • 19.2.10 Sep 07, 2009: BioMerieux Raises Margin Target With Increase Of H1
      • 19.2.11 Apr 23, 2009: bioMerieux Posts Net Sales Of EUR166.9 Million For Q1 2009
      • 19.2.12 Mar 16, 2009: bioMerieux Reports 2008 Results
      • 19.2.13 Jan 20, 2009: bioMerieux Reports Preliminary 2008 Results
      • 19.2.14 Oct 28, 2008: bioMerieux Reports Q3 2008 Results
      • 19.2.15 Jul 23, 2008: bioMerieux Reports 2Q 2008 Results
      • 19.2.16 Apr 29, 2008: bioMerieux Reports Q1 2008 Results
      • 19.2.17 Jan 22, 2008: bioMerieux Reports Q4 2007 Results
      • 19.2.18 Oct 26, 2007: BioMerieux Declares Q3 2007 Results
      • 19.2.19 Sep 17, 2007: BioMerieux Declares H1 2007 Results
      • 19.2.20 Apr 23, 2007: BioMerieux Declares Q1 2007 Results
      • 19.2.21 Jan 17, 2007: BioMerieux Declares Q4 2006 Results
    • 19.3 Research and Development
      • 19.3.1 Mar 08, 2010: ExonHit and bioMerieux Terminate Colon Cancer Program
      • 19.3.2 Jan 07, 2010: Philips, bioMérieux Partner To Develop Automated Handheld Diagnostic Testing Solutions
      • 19.3.3 Nov 17, 2009: bioMerieux Seals Agreement With GSK
      • 19.3.4 Apr 03, 2008: bioMérieux, University of Sunderland Collaborate In New Research To Improve The Identification Of Pseudomonas aeruginosa
      • 19.3.5 Jan 08, 2008: BioMerieux Transfers Certain R&D and Manufacturing Activities To France
    • 19.4 Corporate Communications
      • 19.4.1 Jan 04, 2011: bioMerieux Appoints James Whelan As Executive Vice President, Commercial Services
      • 19.4.2 Jul 19, 2010: bioMerieux Appoints Jacques Baudin As Vice President, Commercial Operations Information Technology
      • 19.4.3 May 17, 2010: bioMerieux Manuel Mendez As Executive Vice President, Commercial Operations
      • 19.4.4 Nov 03, 2009: bioMerieux Appoints Alain Pluquet As CTO
      • 19.4.5 Dec 22, 2008: bioMerieux Appoints New Board Member
      • 19.4.6 Sep 01, 2008: bioMerieux Appoints Corporate Vice President
      • 19.4.7 Jun 12, 2008: BioMerieux Appoints New Board Member
      • 19.4.8 Dec 19, 2006: BioMerieux Appoints New CEO
      • 19.4.9 Sep 18, 2006: BioMerieux Appoints New Board Member
    • 19.5 Legal and Regulatory
      • 19.5.1 May 15, 2008: bioMerieux and FIND Signs MOU
    • 19.6 Government and Public Interest
      • 19.6.1 Jun 30, 2011: Global Call For Action To Fight Antibiotic Resistance Discussed At Fondation Mérieux's Conference Center For Third Edition Of World HAI Forum
    • 19.7 Product News
      • 19.7.1 May 24, 2011: BioMerieux Receives FDA Clearance For NucliSENS EasyQ MRSA
      • 19.7.2 Apr 12, 2011: bioMérieux Installs 100th PREVI Isola Streaker At Grady Health System
      • 19.7.3 May 10, 2010: bioMérieux and GSK Enter Into Alliance To Develop Molecular Theranostic Test For Cancer Treatment Selection
      • 19.7.4 Mar 11, 2010: Biomerieux Introduces ChromID VRE
      • 19.7.5 Nov 17, 2009: BioMerieux Signs An Agreement With GSK To Develop Predictive Test For Selecting Breast Cancer Treatment
  • 20 Appendix
    • 20.1 Research Methodology
    • 20.2 Secondary Research
    • 20.3 Primary Research
    • 20.4 Models
    • 20.5 Forecasts
    • 20.6 Expert Panels
    • 20.7 GlobalData Consulting
    • 20.8 Currency Conversion
    • 20.9 Contact Us
    • 20.10 Disclaimer
    • 1.1 List of Tables
      • Table 1: bioMerieux S.A., Key Facts, 2010
      • Table 2: bioMerieux S.A., SWOT Analysis, 2010
      • Table 3: In Vitro Diagnostics, Global, Company Share by Revenue ($m), 2010
      • Table 4: bioMerieux S.A., In Vitro Diagnostics, Global, Revenue ($m) and Market Share (%), 2010
      • Table 5: bioMerieux S.A., In Vitro Diagnostics, Asia-Pacific, Revenue ($m) and Market Share (%), 2010
      • Table 6: bioMerieux S.A., In Vitro Diagnostics, Europe, Revenue ($m) and Market Share (%), 2010
      • Table 7: bioMerieux S.A., In Vitro Diagnostics, Middle East and Africa, Revenue ($m) and Market Share (%), 2010
      • Table 8: bioMerieux S.A., In Vitro Diagnostics, North America, Revenue ($m) and Market Share (%), 2010
      • Table 9: bioMerieux S.A., In Vitro Diagnostics, South and Central America, Revenue ($m) and Market Share (%), 2010
      • Table 10: bioMerieux S.A., In Vitro Diagnostics, Global, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 11: bioMerieux S.A., In Vitro Diagnostics, Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 12: bioMerieux S.A., In Vitro Diagnostics, Australia, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 13: bioMerieux S.A., In Vitro Diagnostics, China, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 14: bioMerieux S.A., In Vitro Diagnostics, India, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 15: bioMerieux S.A., In Vitro Diagnostics, Japan, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 16: bioMerieux S.A., In Vitro Diagnostics, Other Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 17: bioMerieux S.A., In Vitro Diagnostics, Europe, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 18: bioMerieux S.A., In Vitro Diagnostics, France, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 19: bioMerieux S.A., In Vitro Diagnostics, Germany, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 20: bioMerieux S.A., In Vitro Diagnostics, Italy, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 21: bioMerieux S.A., In Vitro Diagnostics, Spain, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 22: bioMerieux S.A., In Vitro Diagnostics, United Kingdom, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 23: bioMerieux S.A., In Vitro Diagnostics, Other Europe, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 24: bioMerieux S.A., In Vitro Diagnostics, Middle East and Africa, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 25: bioMerieux S.A., In Vitro Diagnostics, North America, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 26: bioMerieux S.A., In Vitro Diagnostics, Canada, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 27: bioMerieux S.A., In Vitro Diagnostics, United States, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 28: bioMerieux S.A., In Vitro Diagnostics, South and Central America, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 29: bioMerieux S.A., In Vitro Diagnostics, Brazil, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 30: bioMerieux S.A., In Vitro Diagnostics, Other South and Central America, Revenue ($m) and Market Share (%) by Category, 2010
      • Table 31: bioMerieux S.A., Key Employees
      • Table 32: bioMerieux S.A., Other Locations
      • Table 33: bioMerieux S.A., Subsidiaries
      • Table 34: bioMerieux S.A., Deals Volume Summary, 2006 to YTD 2011
      • Table 35: bioMerieux S.A., Deals Summary, 2006 to YTD 2011
      • Table 36: AviaraDx Raises $8 Million In Series A Financing
      • Table 37: AdvanDx Secures $15 Million Series C Financing
      • Table 38: Arcturus Bioscience Secures $8 Million In Financing
      • Table 39: bioMerieux Enters Into Licensing Agreement With ProteoSys
      • Table 40: ExonHit Therapeutics Amends Its Licensing Agreement With bioMerieux
      • Table 41: bioMerieux Enters Into An Agreement With NuGEN Technologies
      • Table 42: biomerieux Signs A Licensing Agreement With Labtech Systems
      • Table 43: bioMerieux Enters Into Licensing Agreement With NorChip
      • Table 44: Bio-Rad Laboratories Enters Into Licensing Agreement With bioMerieux
      • Table 45: Lumora Enters Into Licensing Agreement With bioMerieux
      • Table 46: bioMerieux Extends Its Licensing Agreement With ExonHit Therapeutics
      • Table 47: bioMerieux Enters Into Licensing Agreement With DiagnoSwiss
      • Table 48: Roche Diagnostics Signs An Agreement With bioMerieux
      • Table 49: Biomerieux Enters Into Co-Development Agreement With Biocartis
      • Table 50: bioMerieux Signs Co-Development Agreement With GlaxoSmithKline
      • Table 51: Ferrer inCode Enters Into An Agreement With bioTheranostics
      • Table 52: Royal Philips Electronics Enters Into An Agreement With bioMerieux
      • Table 53: bioMerieux Enters Into Research Agreement With CEA
      • Table 54: bioMerieux Enters Into An Agreement With GlaxoSmithKline
      • Table 55: bioTheranostics Signs An Agreement With Lab21
      • Table 56: bioMerieux Enters Into Research Agreement With Foundation for Innovative New Diagnostics
      • Table 57: bioMerieux Enters Into An Agreement With Hitachi High-Technologies
      • Table 58: bioMerieux Enters Into An Agreement With Wescor
      • Table 59: bioMerieux Forms Joint Venture With Shanghai Kehua Bio-engineering
      • Table 60: Sysmex Forms Joint Venture With bioMerieux
      • Table 61: Sysmex Corporation Enters Into An Agreement With Biomerieux
      • Table 62: AdvanDx Enters Into An Agreement With bioMerieux
      • Table 63: Biomerieux Enters Into An Agreement With Cepheid
      • Table 64: bioMerieux Forms Joint Venture With Chinese Academy of Medical Sciences
      • Table 65: B•R•A•H•M•S Enters Into An Agreement With bioMerieux
      • Table 66: Abaxis Enters Into Licensing Agreement With bioMerieux
      • Table 67: Gen-Probe Enters Into Licensing Agreement With bioMerieux
      • Table 68: LabCorp Enters Into An Agreement With Arcturus Bioscience
      • Table 69: Affymetrix Extends Its Agreement With bioMerieux
      • Table 70: Gen-Probe Enters Into An Agreement With bioMerieux
      • Table 71: Labtech Systems Completes Private Placement Of $1.79 Million With Biomerieux
      • Table 72: bioMerieux Sells Hemostasis Business To Trinity Biotech
      • Table 73: bioMerieux Completes Acquisition Of AES Laboratoire
      • Table 74: bioMerieux Acquires Argene
      • Table 75: bioMerieux Completes Acquisition Of Meikang Biotech (Shanghai)
      • Table 76: bioMerieux Sells Minority Stake In ExonHit Therapeutics
      • Table 77: bioMerieux Acquires PML Microbiologicals From Pelican Life Sciences
      • Table 78: bioMerieux Acquires AviaraDx
      • Table 79: bioMerieux Acquires AB BIODISK
      • Table 80: bioMerieux Acquires BTF From Kestrel Capital
      • Table 81: Biomerieux Acquires Biomedics
      • Table 82: USD to Local Currency, Average Exchange Rate, 2010
    • 1.2 List of Figures
      • Figure 1: In Vitro Diagnostics, Global, Market Share (%), 2010
      • Figure 2: bioMerieux S.A., In Vitro Diagnostics, Global, Market Share (%), 2010
      • Figure 3: bioMerieux S.A., In Vitro Diagnostics, Asia-Pacific, Market Share (%), 2010
      • Figure 4: bioMerieux S.A., In Vitro Diagnostics, Europe, Market Share (%), 2010
      • Figure 5: bioMerieux S.A., In Vitro Diagnostics, North America, Market Share (%), 2010
      • Figure 6: bioMerieux S.A., In Vitro Diagnostics, South and Central America, Market Share (%), 2010
      • Figure 7: bioMerieux S.A., In Vitro Diagnostics, Global, Category Revenue Share (%), 2010
      • Figure 8: bioMerieux S.A., In Vitro Diagnostics, Global, Market Share (%) by Category, 2010
      • Figure 9: bioMerieux S.A., In Vitro Diagnostics, Asia-Pacific, Category Revenue Share (%), 2010
      • Figure 10: bioMerieux S.A., In Vitro Diagnostics, Asia-Pacific, Market Share (%) by Category, 2010
      • Figure 11: bioMerieux S.A., In Vitro Diagnostics, Australia, Category Revenue Share (%), 2010
      • Figure 12: bioMerieux S.A., In Vitro Diagnostics, Australia, Market Share (%) by Category, 2010
      • Figure 13: bioMerieux S.A., In Vitro Diagnostics, China, Category Revenue Share (%), 2010
      • Figure 14: bioMerieux S.A., In Vitro Diagnostics, China, Market Share (%) by Category, 2010
      • Figure 15: bioMerieux S.A., In Vitro Diagnostics, India, Category Revenue Share (%), 2010
      • Figure 16: bioMerieux S.A., In Vitro Diagnostics, India, Market Share (%) by Category, 2010
      • Figure 17: bioMerieux S.A., In Vitro Diagnostics, Japan, Category Revenue Share (%), 2010
      • Figure 18: bioMerieux S.A., In Vitro Diagnostics, Japan, Market Share (%) by Category, 2010
      • Figure 19: bioMerieux S.A., In Vitro Diagnostics, Other Asia-Pacific, Category Revenue Share (%), 2010
      • Figure 20: bioMerieux S.A., In Vitro Diagnostics, Other Asia-Pacific, Market Share (%) by Category, 2010
      • Figure 21: bioMerieux S.A., In Vitro Diagnostics, Europe, Category Revenue Share (%), 2010
      • Figure 22: bioMerieux S.A., In Vitro Diagnostics, Europe, Market Share (%) by Category, 2010
      • Figure 23: bioMerieux S.A., In Vitro Diagnostics, France, Category Revenue Share (%), 2010
      • Figure 24: bioMerieux S.A., In Vitro Diagnostics, France, Market Share (%) by Category, 2010
      • Figure 25: bioMerieux S.A., In Vitro Diagnostics, Germany, Category Revenue Share (%), 2010
      • Figure 26: bioMerieux S.A., In Vitro Diagnostics, Germany, Market Share (%) by Category, 2010
      • Figure 27: bioMerieux S.A., In Vitro Diagnostics, Italy, Category Revenue Share (%), 2010
      • Figure 28: bioMerieux S.A., In Vitro Diagnostics, Italy, Market Share (%) by Category, 2010
      • Figure 29: bioMerieux S.A., In Vitro Diagnostics, Spain, Category Revenue Share (%), 2010
      • Figure 30: bioMerieux S.A., In Vitro Diagnostics, Spain, Market Share (%) by Category, 2010
      • Figure 31: bioMerieux S.A., In Vitro Diagnostics, United Kingdom, Category Revenue Share (%), 2010
      • Figure 32: bioMerieux S.A., In Vitro Diagnostics, United Kingdom, Market Share (%) by Category, 2010
      • Figure 33: bioMerieux S.A., In Vitro Diagnostics, Other Europe, Category Revenue Share (%), 2010
      • Figure 34: bioMerieux S.A., In Vitro Diagnostics, Other Europe, Market Share (%) by Category, 2010
      • Figure 35: bioMerieux S.A., In Vitro Diagnostics, Middle East and Africa, Category Revenue Share (%), 2010
      • Figure 36: bioMerieux S.A., In Vitro Diagnostics, Middle East and Africa, Market Share (%) by Category, 2010
      • Figure 37: bioMerieux S.A., In Vitro Diagnostics, North America, Category Revenue Share (%), 2010
      • Figure 38: bioMerieux S.A., In Vitro Diagnostics, North America, Market Share (%) by Category, 2010
      • Figure 39: bioMerieux S.A., In Vitro Diagnostics, Canada, Category Revenue Share (%), 2010
      • Figure 40: bioMerieux S.A., In Vitro Diagnostics, Canada, Market Share (%) by Category, 2010
      • Figure 41: bioMerieux S.A., In Vitro Diagnostics, United States, Category Revenue Share (%), 2010
      • Figure 42: bioMerieux S.A., In Vitro Diagnostics, United States, Market Share (%) by Category, 2010
      • Figure 43: bioMerieux S.A., In Vitro Diagnostics, South and Central America, Category Revenue Share (%), 2010
      • Figure 44: bioMerieux S.A., In Vitro Diagnostics, South and Central America, Market Share (%) by Category, 2010
      • Figure 45: bioMerieux S.A., In Vitro Diagnostics, Brazil, Category Revenue Share (%), 2010
      • Figure 46: bioMerieux S.A., In Vitro Diagnostics, Brazil, Market Share (%) by Category, 2010
      • Figure 47: bioMerieux S.A., In Vitro Diagnostics, Other South and Central America, Category Revenue Share (%), 2010
      • Figure 48: bioMerieux S.A., In Vitro Diagnostics, Other South and Central America, Market Share (%) by Category, 2010
      • Figure 49: bioMerieux S.A., Deals Volume Summary, 2006 to YTD 2011
+44 20 8816 8548

Ask a question about Biomerieux Sa Market Share Analysis

Enter the characters you see in the picture below
Captcha